<DOC>
	<DOCNO>NCT01008345</DOCNO>
	<brief_summary>Randomized study . Patients coronary artery disease equivalent randomize receive atorvastatin 40 mg/day + placebo vs. atorvastatin 40 mg/day + ezetimibe 40 mg/day . Oxidized LDL cholesterol measure baseline 8 week treatment . Hypothesis ezetimibe low oxidize LDL</brief_summary>
	<brief_title>Effect Ezetimibe Oxidized Low-density Lipoprotein ( LDL ) Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>CAD CAD equivalent Prior CABG PCI within 3 month Prior use ezetimibe within 3 month Receiving atorvastatin 40 mg/day 80 mg/day dose rosuvastatin CHF NYHA stage &gt; 2 Creatinin clearance &lt; 30 ml/min</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>